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Our objective was to characterize 46 unique, erythromycin-sensitive, and clindamycin-resistant Streptococcus
agalactiae strains from S. Korea that displayed a novel phenotype in double-disk diffusion assay. We used
polymerase chain reaction to determine presence of erythromycin and clindamycin resistance genes, disc dif-
fusion assays to determine resistance phenotype, and microbroth dilution to determine minimal inhibitory
concentration. We detected a novel phenotype in the double-disk diffusion assay for inducible resistance among
46 S. agalactiae strains that were both erythromycin sensitive and clindamycin resistant. Thirty-two strains with
the novel phenotype tested positive for erm(B) by DNA–DNA hybridization; sequencing of the erm(B) gene
revealed mutations in the ribosomal binding site region in the erm(B) open reading frame, which is consistent
with a lack of erythromycin resistance phenotype. Although identified from patients at multiple hospitals,
genotyping suggested that the strains are closely related. The new phenotype shows increased sensitivity to
clindamycin in the presence of erythromycin.
Introduction
Streptococcus agalactiae (S. agalactiae) is a commoncause of severe infections in neonates, and causes bac-
teremia and endocarditis in immunocompromised popula-
tions.5 S. agalactiae remains sensitive to treatment with
penicillin; erythromycin or clindamycin is the recommended
alternative for patients who are b-lactam intolerant.4 Re-
sistance to erythromycin and clindamycin has increased
during the last decade and is mainly attributed to the
erythromycin-conferring methylase genes (erm). The erm genes
code for ribosomal methylase and confer cross resistance
to clindamycin either through constitutive or inducible resis-
tance mechanisms.1 Thus, resistance to erythromycin and
clindamycin often occurs together. Resistance to erythromycin
alone can be conferred by the efflux gene mef, and resistance to
clindamycin alone can be conferred by the lnu(B) gene that
expresses a specific nucleotidyl transferase.5
As part of a study of antibiotic resistance determinants in
S. agalactiae collected in South Korea in 2006–2007, we
identified 46 strains that displayed high resistance to clin-
damycin, yet were sensitive to erythromycin. We performed
the double-disk diffusion testing for inducible resistance and
observed a novel phenotype characterized by a channel of
sensitivity to clindamycin in the presence of erythromycin.
The characteristics of this novel phenotype with increased
sensitivity to clindamycin in the presence of erythromycin
are reported here.
Materials and Methods
Study populations and S. agalactiae isolation
The study collection included 197 colonizing isolates col-
lected from 140 asymptomatic pregnant women (35–37
weeks of gestation) and 233 clinical isolates collected from
231 patients with S. agalactiae infection. One unique isolate
per individual was selected for further study (n¼ 371).
Colonizing isolates were collected from pregnant women
receiving prenatal care at four hospitals, Eulji Hospitals in
Seoul and Daejeon, Cheil Hospital in Seoul, and Motae
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Women’s Hospital in Daejeon, South Korea, between 2006
and 2007. Invasive S. agalactiae strains were isolated from
specimens sent for microorganism culture from hospitals and
clinics throughout the country between January 2006 and
March 2007.7 Written informed consent permitting use of
collected specimens and medical records for research pur-
poses was obtained from each patient. Mucus or discharge
was collected from patients with infection, and rectal swabs
and urine from pregnant women. All isolates were cultured
by using a selective medium (Todd-Hewitt broth supple-
mented with gentamicin [8 mg/ml] and nalidixic acid [15 mg/
ml], or with colistin [10 mg/ml] and nalidixic acid [15 mg/
ml]) to inhibit growth of bacteria other than S. agalactiae. The
identity of S. agalactiae strains was confirmed by catalase test
followed by a latex agglutination assay (Streptex; Murex
Biotech Ltd.). Antibiotic susceptibility for S. agalactiae was
tested by two methods: (1) minimal inhibitory concentra-
tion (MIC) was determined by broth dilution assays; (2) disc
diffusion was used to study inducible resistance to clin-
damycin in the presence of erythromycin and to identify the
novel keyhole phenotype. Strains with MIC 0.25 mg/ml
were designated as erythromycin/clindamycin susceptible,
whereas MIC 1 mg/ml were designated as erythromycin/
clindamycin resistant. Follow-up disc diffusion testing used
commercial antibiotic discs (Oxoid) and Mueller–Hinton
with 5% (v/v) sheep blood with erythromycin and clin-
damycin discs and were interpreted using published Clinical
and Laboratory Standards Institute standards. If an isolate
was either erythromycin-resistant/clindamycin-susceptible
or erythromycin-susceptible/clindamycin-resistant, we per-
formed a disk induction test by placing clindamycin (2mg) and
erythromycin (15 mg) disks 12 mm apart following CLSI rec-
ommendations.2 The plates were examined after incubation at
358C, 5% CO2 for 20–24 hours; an isolate with a clindamycin
disk diffusion zone blunted on the side closest to erythro-
mycin (D test) was considered to be inducible. Strains dem-
onstrating the new phenotype with the clear channel of
inhibition between the clindamycin and erythromycin discs
were re-tested with different lots of antibiotic discs and media
to rule out nonspecific effects. Serotype was determined using
the S. agalactiae kit (Essum).
Detection of resistance genes
Purified S. agalactiae genomic DNA was arrayed on Vivid
Gene Array slides (Pall), as previously described.9 Poly-
merase chain reaction (PCR) amplification of antibiotic
resistance genes was performed using S. agalactiae overnight
cultures, 50 pmol of each primer, and 45 ml of Accuprime
super mix II (Invitrogen). Primers to detect erm(B), lnu(B),
erm(A), and mef(A) were described previously and used to
prepare labeled probes.7 The presence of antibiotic resistance
genes was determined using high-throughput DNA–DNA
hybridization as previously described,2 and PCR was per-
formed when hybridization results were inconclusive.
The lnu(B) gene was identified using DNA–DNA hybrid-
ization with a probe targeting a 944 bp region of the lnu(B)
gene, and hybridization conditions would have detected
signal in the absence of a perfect probe–DNA match. For
samples that were lnu(B) negative by DNA–DNA hybrid-
ization, PCR amplifications were attempted using both col-
ony PCR and purified genomic DNA as template in
replicates. If neither of the PCR gave expected size products,
the strains were designated as lnu(B) negative.
A 639 bp fragment of ermB gene was amplified using
50-GAA AAG GTA CTC AAC CAA ATA-30 and 50-AGT AAC
GGT ACT TAA ATT GTT TAC-30 (reverse). Primers designed
to PCR amplify the entire erm(B) gene in the novel phenotype
strains were not successful; hence, a 1,000 bp region encom-
passing the erm and adjacent genetic region in S. agalactiae was
amplified using primers GTATTGTCCGAGAGTGATTGG
TC and AACTTACCCGCCATACCACAG from previously
published literature on erm-positive S. agalactiae transposon
Tn3872.8 PCR conditions used included denaturation at 948C
for 2 minutes, followed by 30 cycles at 948C for 30 seconds of
denaturation, 558C for 1 minute, and extension at 728C for
2 minutes. PCR products were purified and sequenced at
from 50 and 30 ends at the DNA Sequencing core, University of
Michigan.
Results
Figure 1 shows an example of the novel phenotype in
double-disk diffusion assay, induced clindamycin sensitivity
FIG. 1. Erythromycin and clindamycin double-disk diffusion assays of Streptococcus agalactiae from South Korea. Strains
were grown to 0.5% McFarland and inoculated on to Mueller–Hinton with 5% (v/v) sheep blood and allowed to grow at
358C for 16–18 hours. The left panel shows erythromycin-induced clindamycin resistance seen as a blunted ‘‘D’’ inhibition
zone. The right panel shows the novel keyhole phenotype seen as an enhancement of the zone of inhibition between
erythromycin and clindamycin discs in erythromycin-sensitive and clindamycin-resistant S. agalactiae strains. Color images
available online at www.liebertonline.com/mdr.
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in a keyhole phenotype. The 46 strains with the novel phe-
notype were isolated from 28 patients with disease caused by
S. agalactiae and 18 pregnant patients undergoing screening
for S. agalactiae. The keyhole phenotype strains were isolated
from urine (n¼ 25), rectal swabs (n¼ 7), vaginal swabs
(n¼ 4), cervical swabs (n¼ 3), pus (n¼ 2), wound (n¼ 1), and
4 from other sites. In seven individuals the keyhole pheno-
type colonized multiple sites (only one strain per individual
was counted toward the 46 strains exhibiting the novel
phenotype). Forty-three of these strains (95%) were serotype
III; the three remaining strains were serotype Ib and Ia. To
determine the relatedness of the strains with the phenotype,
we sequenced the S. agalactiae adpH gene to identify poly-
morphisms. The variable adpH gene has a high number of
mutations that are used to differentiate between strains using
multi-locus sequence typing. We did not find any sequence
differences in the adpH genes from the 46 S. agalactiae strains
exhibiting the novel phenotype, suggesting that the strains
are closely related genetically.
To identify the cause of clindamycin and erythromycin
resistance, we screened for the presence of several genes. The
lnu(B) gene is associated with clindamycin resistance, and
42/46 of the erythromycin-susceptible, clindamycin-resistant
strains with the keyhole phenotype had lnu(B) by PCR
(Table 1). One isolate was lnu(B) positive by hybridization
but tested lnu(B) negative by PCR (data not shown). The
three other strains with the keyhole phenotype were lnu(B)
negative (Table 1). Erythromycin and clindamycin resistance-
conferring genes erm(A) and mef(A) were not found in any of
the strains exhibiting the novel phenotype.
Thirty-two strains displaying the keyhole phenotype
were erm(B) positive by DNA–DNA hybridization and PCR
(Table 1), yet remained phenotypically erythromycin sensi-
tive. PCR amplification of the erm(B) gene revealed a point
mutation in the leader sequence (AGGAGT to ATTAGA)
and three point mutations in the coding region of the erm(B)
gene; at 222 bp (C to T), 224 bp (T to C), and 299 bp (A to G),
respectively. These mutations were absent in 30 erythromy-
cin and clindamycin-resistant strains that did not show the
keyhole phenotype (data not shown). We were unable to
amplify a region of 57 bp from the 30 coding region of erm(B)
as well as the region immediately downstream of the erm(B)
gene in the strains exhibiting the novel phenotype.
MIC values for clindamycin resistance were >8mg/ml for
all strains with the keyhole phenotype (data not shown). We
selected five strains to determine the effect of erythromycin
on MIC of clindamycin; all exhibited the keyhole phenotype
and were erm(B) and lnu(B) positive. However, when the
strains were inoculated with erythromycin and clindamycin,
the results were mixed; three out of the five strains tested
had decreased MIC values for clindamycin when inoculated
with low concentrations of erythromycin; the clindamycin
MIC values for two other strains remained unchanged (data
not shown).
Discussion
We characterized 46 S. agalactiae with a unique keyhole
phenotype that is best described as inducible clindamycin
sensitivity. The 46 clindamycin-resistant and erythromycin-
sensitive strains with the phenotype were identified from
both clinical and colonizing isolates in South Korea between
2006 and 2007 and did not cluster by hospital. However,
genotyping suggested that the strains were closely related.
All strains were more susceptible to clindamycin in the
presence of erythromycin in the double-disk diffusion assay
than suggested from MICs or from a single-disc diffusion
assay. Almost all (94%) strains carried the lnuB gene, which
codes for clindamycin resistance, and 70% carried a non-
functional ermB, which is consistent with erythromycin-
susceptible phenotype of these strains. The mechanistic basis
of the channel of zone inhibition between the erythromycin
and the clindamycin disks in strains exhibiting the keyhole
phenotype in S. agalactiae strains is not known. Since the
novel phenotype was observed in both lnu(B)-positive and
lnu(B)-negative strains as well as erm(B)-positive and erm(B)-
negative strains, we postulate that the mechanism underly-
ing the novel phenotype is either independent of the erm(B)
and lnu(B) genes or is associated with erm and lnu variants
that were not detected by probes used for DNA–DNA
hybridization or primers used for PCR methods in this study.
Sequence analysis of the erm(B) region in keyhole pheno-
type strains that were positive for erm(B) revealed point
mutations in both the Shine Dalgarno ribosome binding se-
quences and erm(B) coding regions. Mutations in the Shine
and Dalgarno sites are associated with reduced translation
and may be responsible for the erythromycin sensitivity of
these erm(B)-containing strains. Two point mutations within
the erm(B) coding region were also detected in all strains
exhibiting the novel phenotype that were positive for erm(B).
One mutation codes for an amino acid substitution from
Asp174Thr on the erm(B) coding region; Asp174 has been
implicated to be important in the binding of the substrate,
S-adenosine methionine to erm(B) in Clostridium3; however,
their functional significance in strains with the keyhole
phenotype is not known. The second mutation, a deletion in
the 30 end of the erm(B) coding region, would also serve to
explain the erythromycin sensitivity of these strains with the
Table 1. Prevalence of Antibiotic Resistance Genes
in 46 Erythromycin-Sensitive, Clindamycin-Resistant
Streptococcus agalactiae Strains Exhibiting a
Keyhole Phenotype in Double-Disk Diffusion Assay
Keyhole phenotype
strain characteristics Number of strains (%)
Site of isolation
Urine 25 (54%)
Rectum 7 (15.2)
Cervix 3 (6.5%)
Vagina 4 (9%)
Othera 7 (15%)
Serotype
III 43 (94%)
Ia 1 (2%)
Ib 2 (4%)
Resistance-conferring genes
ErmB 32 (70%)
LnuB 43 (94%)
ErmA 0 (0%)
MefA 0 (0%)
aOther sites include wound and pus, and sites of collection for
some strain were not available.
S. AGALACTIAE, ERYTHROMYCIN, AND CLINDAMYCIN 123
keyhole phenotype. The presence of identical mutations on
all erm(B)-positive strains exhibiting the keyhole phenotype
implies that the erm(B) gene may have originated from a
common ancestor or have mutated due to similar selective
pressures to lose function. A more detailed molecular typing
and phylogenetic analysis of these strains is planned.
In the laboratory, constitutively resistant mutants can be
selected at high frequencies from inducible resistant strains
in the presence of clindamycin; in a clinical setting, this im-
plies that there is a risk for selecting clindamycin-resistant
strains if infections are treated with clindamycin.6 We do not
know the implications of the keyhole phenotype in vivo, but
it is possible that these strains would respond to erythro-
mycin therapy.
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